| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/15/2009 | CN100512876C Coated metal pyrithione particles for treatment of microorganisms |
| 07/15/2009 | CN100512818C Composition for matching with contact lenses and its application |
| 07/15/2009 | CN100512817C Compound injection of Xylazine and preparation technique |
| 07/15/2009 | CN100512816C Application of pyrimidone compounds in preparing medicine |
| 07/15/2009 | CN100512815C Matrine enteric coatel tablet and its preparation method |
| 07/15/2009 | CN100512814C Application of indole-2,3-diketone in preparing antiphlogistic medicament |
| 07/15/2009 | CN100512813C Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases |
| 07/15/2009 | CN100512812C Method of extracting red indigo peucin and red indigo peucin cinnamic ester from Korean Angelica |
| 07/15/2009 | CN100512811C Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 07/15/2009 | CN100512810C Premixed amiodarone parenteral solution and method for making the same |
| 07/15/2009 | CN100512809C Compounds and methods of treating transplant rejection |
| 07/15/2009 | CN100512808C Externally applied compound amino acid prepn for promoting wound healing and its preparation process and application thereof |
| 07/15/2009 | CN100512807C Pharmaceutical for preventing and curing acute gout, tumor and hepatic/pulmonary fibrosis and preparation method thereof |
| 07/15/2009 | CN100512806C Therapeutic patch with polysiloxane matrix comprising capsaicin |
| 07/15/2009 | CN100512805C Sesquiterpene injection, preparing method and use thereof |
| 07/15/2009 | CN100512803C Natural carotene soft capsule and its production method |
| 07/15/2009 | CN100512798C Method for preparing submicron particle suspensions |
| 07/15/2009 | CN100512646C Deep penetrating anti-microbial compositions |
| 07/14/2009 | USRE40851 3,3-diphenylpropylamines, their use and preparation |
| 07/14/2009 | USRE40849 Miixture of N-acetylcysteine, vitamin C, and N-acetylglucosamine; cell membrane absorption; orally administered; may contain alpha-lipoic acid, silymarin, querecitin, 1-glutamine, and/or a probiotic; hepatitis, human immunodeficiency virus, cancer; gastrointestinal and respiratory system disorders |
| 07/14/2009 | US7560610 Using transgenic hypercellular nonhuman organisms as cell proliferating gene therapeutic tools |
| 07/14/2009 | US7560597 2′,4′-dichloro-biphenyl-4-yl-hydroxy-ketones and related compounds and their use as therapeutic agents |
| 07/14/2009 | US7560591 Benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 07/14/2009 | US7560586 Acid and ester compounds and methods of using the same |
| 07/14/2009 | US7560584 Immunomodulatory compounds and methods of use thereof |
| 07/14/2009 | US7560576 Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
| 07/14/2009 | US7560570 Inhibitors of fatty acid amide hydrolase |
| 07/14/2009 | US7560569 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity |
| 07/14/2009 | US7560568 2-(1H-Benzimidazol-1-yl)-4-({[2-(trifluoromethyl)phenyl]methyl}-oxy)-1,3-thiazole-5-carboxamide; for treatment of neoplasm |
| 07/14/2009 | US7560565 Method for preparing derivatives of 3-hydroxypicolinic acid |
| 07/14/2009 | US7560564 Heterocyclic diamide invertebrate pest control agents |
| 07/14/2009 | US7560562 1-methyl-3-ethoxymethyl-4-(3,4-dichlorophenyl)-piperidine; nervous system disorders |
| 07/14/2009 | US7560561 Such as terfenadine carboxylic acid metabolite and carebastine using a 4-(4-halo-1-oxobutyl)-alpha,alpha-dimethyl-alpha-substituted toluene intermediate |
| 07/14/2009 | US7560559 new crystalline form; prepared from acetonitrile monosolvate; active pharmaceutical ingredient of SINGULAIR (reg), and for the treatment of asthma and allergic rhinitis |
| 07/14/2009 | US7560553 Use of fuse nicotinamides to promote neurogenesis |
| 07/14/2009 | US7560552 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 07/14/2009 | US7560551 Aurora kinase modulators and method of use |
| 07/14/2009 | US7560548 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 07/14/2009 | US7560546 Tyrosine kinase inhibitors |
| 07/14/2009 | US7560544 Immunomodulators; hepatitis C virus; 5-amino-3-(O-D-ribofuranosylthiazolo[4,5-d]pyrimidine-2,7(3H,6H) dione (7-thia-8-oxoguanosine) |
| 07/14/2009 | US7560543 Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression |
| 07/14/2009 | US7560527 Modified adenovirus fibre and uses |
| 07/14/2009 | US7560493 Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active principle and at least one N-vinylimidazole polymer or copolymer |
| 07/14/2009 | US7560491 Z-stilbenes derivatives and the pharmaceutical composition thereof |
| 07/14/2009 | US7560490 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof |
| 07/14/2009 | US7560489 Stabilized prostaglandin E composition |
| 07/14/2009 | US7560488 orally administering 250 mg of 2',4'-difluoro-4-hydroxy-[1,1'-biphenyl]-3-carboxylic acid (Diflunisal) twice per day; for neuropathic pain, cardiomyopathy, amyloidosis, following liver transplantation |
| 07/14/2009 | US7560487 In particular, kidneys |
| 07/14/2009 | US7560486 An isotonic lipid emulsion free of vegetable oils:(i) 78 to 95% by weight of medium chain triglycerides (MCT), (ii) 5 to 22% by weight of fish oil; to increase the amount of omega-3 fatty acids of cell membranes of organs and tissues |
| 07/14/2009 | US7560485 provides a relief from peripheral arterial disease, no side effect, improving quality of life |
| 07/14/2009 | US7560484 Active ingredients of 9,12,13-trihydroxy-10-octadecenoic acid and derivatives as safe and effective vaccine adjuvants; side effects reduction; immunopotentiation; plant extracts; viral diseases; inoculation intranasal, transdermal, oral |
| 07/14/2009 | US7560483 Synthesizing 1- (acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amenable |
| 07/14/2009 | US7560482 Aspartyl protease inhibitor; antimalaria agents |
| 07/14/2009 | US7560481 Indoles are cannabinoid receptor ligands |
| 07/14/2009 | US7560480 Alkyl-containing 5-acylindolinones, the preparation thereof and their use as medicaments |
| 07/14/2009 | US7560479 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 07/14/2009 | US7560478 facilitates handling; 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionic acid; methyl 3-[4-(indan-2-yloxy)-3-(1-methyl-1H-indazol-5-yl)-5-nitrophenyl]propionate; crystallization; industrial scale |
| 07/14/2009 | US7560477 Compounds active in sphingosine 1-phosphate signaling |
| 07/14/2009 | US7560476 Microbicidal formulation containing at least one non-halogenated 2-alkyl-4-isothiazolin-3-one selected from substituted and unsubstituted 2-(C1-C4)alkyl-4-isothiazolin-3-ones; andat least one of 2,2'-dithiobis(N-methylbenzamide) and 2-methylbenzisothiazolone |
| 07/14/2009 | US7560475 3-(2-{5-methyl-2-[4-(trifluoromethyl)piperidin-1-yl]-1,3-thiazol-4-yl}ethoxy)phenyl]acetic acid,peroxime proliferator-activated receptor antagonists; side effect reduction; very low toxicity, especially hepatotoxicity; metabolic disorders; antidiabetic agents; anticholesterol agents; antilipemic agents |
| 07/14/2009 | US7560474 Derivatives of pyridilethanol (phenylethyl) amines as inhibitors of cholesterol biosynthesis, process for their preparation and pharmaceutical compositions containing them |
| 07/14/2009 | US7560473 Amine derivative with potassium channel regulatory function, its preparation and use |
| 07/14/2009 | US7560472 1-cyclohexylethyl ammonium salts; for inhibiting gastric juice secretion |
| 07/14/2009 | US7560471 5-{4-[1-(2-Ethoxyethyl)-1H-indol-3-yl]piperidin-1-ylmethyl}-2-methoxybenzoic acid; histamine H1 antagonists; bronchial dialtors; asthma; allergic rhinitis; conjunctivitis; dermatitis; urticaria; selective antiallergic effects so less side effect reduction and lower dosage |
| 07/14/2009 | US7560470 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| 07/14/2009 | US7560469 Biphenyl compounds useful as muscarinic receptor antagonists |
| 07/14/2009 | US7560468 Substituted 1,4,8-triazaspiro[4,5]decan-2-one compounds |
| 07/14/2009 | US7560467 Indazolo-tetrahydropyrimidine-carboxamide derivative kinase inhibitors |
| 07/14/2009 | US7560466 N4-(2,2-Dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-N2-(3-chloro-4-methoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE (Fc epsilon RI) and IgG (Fc gamma RI) antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis |
| 07/14/2009 | US7560465 Compositions and methods for delivery of caffeine |
| 07/14/2009 | US7560464 (5-Methoxy-2-pyridin-2-yl-pyrimidin-4-yl)-(5-pyrrolidin-1-yl-pyridin-2-yl)-amine; SK channel modulators (SK=small conductance calcium activated potassium channels); antiepileptic agents; seizures; learning enhancement; cognition activators; mood/psychotic disorders; antidepressants; Parkinson's disease |
| 07/14/2009 | US7560463 Diaryl ethers as opioid receptor antagonists |
| 07/14/2009 | US7560462 Compounds useful for inhibiting CHK1 |
| 07/14/2009 | US7560461 Quinazoline derivatives as kinase inhibitors |
| 07/14/2009 | US7560460 2-[(4-Chlorophenyl)methyl]-1-(4- {2-[(cyclopropylmethyl)-(methylsulfonyl)amino]phenyl }-piperazinyl) -4-(2-(1,2,3,4-tetrahydroisoquinolyl))butane-1,4-dione; obesity/dietietics; melanocortin receptor angonists; prophylaxis/treatment of diseases involving activation of the melanocortin recepetors (MCR) |
| 07/14/2009 | US7560459 Substituted sulfamate anticonvulsant derivatives |
| 07/14/2009 | US7560458 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 07/14/2009 | US7560457 E.g., 9,27-dihydroxy-3-{2-[4-hydroxy-3-methoxycyclohexyl]-1-methylethyl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-37-phenyl 4,9,10,12,13,14,15,18,21,22,23,24,25,26,27,32,33,34,34a-nonadecahydro-3H-23,27-epoxy-18,15-(epoxyimino)pyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(6H,31H)-pentone |
| 07/14/2009 | US7560456 Pesticidal pyridinecarboxamide derivatives |
| 07/14/2009 | US7560455 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 07/14/2009 | US7560454 1-(4-(10,11-dihydro-5H-pyrrolo[2,1-c](1,4)benzodiazepine-10-ylcarbonyl)-2-methyl-benzylcarbamoyl)-4methoxy-L-proline-N,N-dimethylamide; vasopressin agonists particularly useful in the treatment of urogenital disorders central diabetes insipidus, nocturnal enuresis and nocturia; blood disorders |
| 07/14/2009 | US7560453 Labeling and idagnostic imaging of histamine H3 receptor; therapy for Alzheimer's disease, nervous system disorders, antiepileptic agents, neuropathic pain, Parkinson's disease, multiple sclerosis, strokes, sleep disorders, schizophrenia, attention deficit disorders, drug abruse, antiallergens |
| 07/14/2009 | US7560451 Aspartyl protease inhibitors |
| 07/14/2009 | US7560450 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 07/14/2009 | US7560449 Methods and therapeutic combinations for the treatment of demyelination |
| 07/14/2009 | US7560448 Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application |
| 07/14/2009 | US7560447 For oral administering; polyunsaturated fatty acid, phospholipids and controller of methionine metabolism such as folic acid, vitamins, minerals and zinc; Alzheimer'sdisas |
| 07/14/2009 | US7560446 Use of angiotensin II receptor antagonists for treating acute myocardial infarction |
| 07/14/2009 | US7560445 Preparing solution of O,O-dimethyldithiophosphoric acid in organic solvent, extracting O,O-dimethyldithiophosphoric acid into water, reacting with diethyl maleate, then treating with sulfur reagent; for treating ectoparasites |
| 07/14/2009 | US7560444 Formulations comprising low molecular weight heparin and a therapeutic, prophylactic or diagnostic agent; improved bioavailability; side effect reduction |
| 07/14/2009 | US7560443 Mixtures of fructose, sucrose and lactose as a low-calorie bulk sweetener with reduced glycemic index |
| 07/14/2009 | US7560442 For prophylaxis and therapy of diabetes mellitus Type I and Type II, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases (Alzheimer's disease, Parkinson's disease), neuropathic diseases, neuropathic pain and polyneuropathy |
| 07/14/2009 | US7560438 Genetic inhibition by double-stranded RNA |
| 07/14/2009 | US7560437 Therapeutic agent for use in the diagnosis and treatment of cancer and cell proliferative disorders |
| 07/14/2009 | US7560436 Chimeric toll-like receptor (TLR) ligand, agonist; tumor necrosis factor agonists/antagonists; Crohn's Disease; ulcerative colitis |
| 07/14/2009 | US7560435 Therapeutic use of riboside of 5-aminoimidazole-4-carboxamide (acadesine) |
| 07/14/2009 | US7560434 AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases |
| 07/14/2009 | US7560425 Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetes |
| 07/14/2009 | US7560132 Oilseed processing |
| 07/14/2009 | US7560131 High solubility composition with high isoflavone concentration and process of producing same |